Schonfeld Strategic Advisors LLC Lowers Holdings in Oscar Health, Inc. (NYSE:OSCR)

Schonfeld Strategic Advisors LLC decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 91.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,100 shares of the company’s stock after selling 448,595 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in Oscar Health were worth $593,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in OSCR. Tower Research Capital LLC TRC raised its holdings in shares of Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock valued at $89,000 after purchasing an additional 4,185 shares in the last quarter. KBC Group NV raised its stake in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in Oscar Health during the fourth quarter worth $100,000. Alberta Investment Management Corp bought a new stake in Oscar Health during the 4th quarter valued at $138,000. Finally, Virtu Financial LLC purchased a new position in shares of Oscar Health in the 4th quarter valued at $140,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Up 0.3 %

NYSE OSCR opened at $17.11 on Friday. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The company has a fifty day simple moving average of $13.34 and a two-hundred day simple moving average of $14.64. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $4.29 billion, a P/E ratio of -855.07 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm’s quarterly revenue was up 42.2% on a year-over-year basis. During the same quarter last year, the business posted $0.62 EPS. On average, analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.